ARTICLE | Company News
Roche, Japan Tobacco deal
October 25, 2004 7:00 AM UTC
ROCZ licensed from Japan Tobacco exclusive worldwide rights, excluding Japan and Korea, to develop and commercialize JTT-705. The cholesteryl ester transfer protein (CETP) inhibitor is in Phase II t...